-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$19.40226.05% Upside
Relay Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Relay Therapeutics, Inc.?
Relay Therapeutics, Inc. has been rated by research analysts at H.C. Wainwright, Jefferies, Barclays, Bank of America Securities, Oppenheimer in the past 90 days.